← Evidence map

ArticleDrug design, development and therapy2022

Metabolomics Provides Insights into Renoprotective Effects of Semaglutide in Obese Mice.

Xing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

13 papers cite it

2022
2023
2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 36388084